Loading…

Lumibird Group signed a share purchase agreement for the sale of Lumibird Medical to IPG Photonics Corporation for an enterprise value of €300 million, with an earn-out of up to €50 million. The transaction is expected to close in Q4 2026.
“The transaction involves the sale of Lumibird Medical for an enterprise value of €300 million, which may be increased by an earn-out of up to €50 million depending on future performance in 2026 and 2027.”business.sherbrookerecord.com
Summarized from public sources; check the original articles before acting on it.